Home LiteratureArticle Details
PMID: 18975243 Published · ppublish English Case Reports Journal Article

Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.

Neurologia i neurochirurgia polska ·Vol. 42 ·No. 4 ·2008-00-00 ·页码 362-5

Hakan T, Aker FV

Abstract

Neurofibromatosis type 1 (NF1) is one of the most common dominantly inherited disorders. Astrocytomas, especially low-grade optic nerve tumours, are frequently harboured in these patients. In this paper, a case of a lobar cystic glioblastoma and NF1 in a 28-year-old woman is presented. This patient underwent a resection of the glioblastoma, followed a multimodal therapy including radiotherapy and chemotherapy, and survived 41 months. Neurofibromatosis is a multifaceted disease in which primary malignant CNS tumours, such as glioblastoma, can be identified. Glioblastomas in these patients should be managed like the usual ones. They may benefit from treatment with temozolomide, as can GBM patients without NF, thus potentially increasing the patient's overall survival.

MeSH 主题词
Adult Brain Neoplasms/complications,diagnosis,drug therapy,radiotherapy,surgery,therapy Fatal Outcome Female Frontal Lobe/pathology Glioblastoma/complications,diagnosis,drug therapy,radiotherapy,therapy Humans Neurofibromatosis 1/complications,diagnosis,drug therapy,radiotherapy,surgery,therapy
作者与单位
共 2 位作者,点击展开单位 / ORCID
Hakan Tayfun
Acibadem Gomec Sokak A Blok 27/11, Kadikoy, 34718 Istanbul, Turkey. tayfunhakan@yahoo.com
Aker Fugen Vardar
Article Info
Journal
Neurologia i neurochirurgia polska
Abbr.
Neurol Neurochir Pol
ISSN
0028-3843
Corresponding email
Published
2008-00-00
页码
362-5
Language
English
Country/Region
Poland
NLM ID
0101265
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com